New heart valve device tested in canada for severe leaky valve
NCT ID NCT07171060
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early study tests a new device called the Laplace TTVR System, which is designed to replace the tricuspid valve without open-heart surgery. It involves 15 people aged 60-90 with severe tricuspid regurgitation that continues despite medication. The main goal is to see if the device can be safely implanted and works as intended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Laplace TTVR System (a device for replacing the tricuspid valve without open-heart surgery)
What this could lead to
If it works, this could offer a less invasive treatment option for people with severe tricuspid regurgitation who are not helped by medication alone.
What could go wrong
This is a very early, small study (15 people) focused on safety and feasibility. The device may not work as expected, and there are risks from the procedure itself, such as complications from valve implantation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sunnybrook Research Institute
RECRUITINGToronto, Ontario, M4N 3M5, Canada
Contact Email: •••••@•••••